26 results on '"Docetaxel -- Research"'
Search Results
2. Reports Summarize Non-Small Cell Lung Cancer Findings from University of Texas MD Anderson Cancer Center (Clinical Benefit From Docetaxel Plus /- Ramucirumab Is Not Associated With Mutation Status In Metastatic Non-small-cell Lung Cancer ...)
3. Kyoto Prefectural University of Medicine Researcher Publishes New Studies and Findings in the Area of Non-Small Cell Lung Cancer (Prospective Observational Study of Ramucirumab Plus Docetaxel After Combined Chemoimmunotherapy in Patients With ...)
4. New Findings on Non-Small Cell Lung Cancer Described by Investigators at German Centre for Lung Research (DZL) (Clinical Outcomes of Ramucirumab Plus Docetaxel In the Treatment of Patients With Non-small Cell Lung Cancer After Immunotherapy: a ...)
5. Findings from National Hospital Organization Kinki Chuo Chest Medical Center Provides New Data on Non-Small Cell Lung Cancer (Efficacy and Safety of Ramucirumab Plus Docetaxel In Older Patients With Advanced Non-small Cell Lung Cancer: a ...)
6. Research Study Findings from Kyoto Prefectural University of Medicine Update Understanding of Non-Small Cell Lung Cancer (Ramucirumab Plus Docetaxel for Patients with Non-small cell Lung Cancer with Brain Metastases: A Multicenter, Open-Label ...)
7. Investigators from Emory University Report New Data on Non-Small Cell Lung Cancer [A Phase 2 Study of Docetaxel, Ramucirumab, and Pembrolizumab for Patients With Metastatic or Recurrent Non-small-cell Lung Cancer (Nsclc) Who Progressed On ...]
8. New Mitotic Inhibitors Findings Reported from Guangxi Medical University (Microfluidic Plga Microcapsules With Pd-l1 Aptamers and Docetaxel Encapsulation for Enhancing Tumor Immunity)
9. New Non-Small Cell Lung Cancer Findings from Yokohama Municipal Citizen's Hospital Reported (A Randomized Comparison of Nivolumab Versus Nivolumab Plus Docetaxel for Previously Treated Advanced or Recurrent Ici-naive Non-small Cell Lung Cancer: ...)
10. Studies from U.S. Biotest Inc. Have Provided New Data on Carcinomas (Local Administration of Large Surface Area Microparticle Docetaxel To Solid Carcinomas Induces Direct Cytotoxicity and Immune-mediated Tumoricidal Effects: Preclinical and ...)
11. Study Findings from Mie Chuo Medical Center Broaden Understanding of Monoclonal Antibodies (Is the Efficacy of Adding Ramucirumab to Docetaxel Related to a History of Immune Checkpoint Inhibitors in the Real-World Clinical Practice?)
12. New Squamous Cell Carcinoma Research Reported from Fujian Medical University Cancer Hospital (Cost-Effectiveness of Nivolumab Immunotherapy vs. Paclitaxel or Docetaxel Chemotherapy as Second-Line Therapy in Advanced Esophageal Squamous Cell ...)
13. Reports from Vienna Highlight Recent Research in Non-Small Cell Lung Cancer (Nintedanib plus Docetaxel after Immune Checkpoint Inhibitor Failure in Patients with Advanced Non-Small-Cell Lung Cancer: A Case Series)
14. Study Results from West China Hospital of Sichuan University Provide New Insights into Squamous Cell Carcinoma [Case Report: Partial Response Following Nivolumab Plus Docetaxel in a Patient With EGFR Exon 20 Deletion/Insertion (p.N771delinsGF) ...]
15. New Data from Cancer Hospital Illuminate Findings in Non-Small Cell Lung Cancer (Cost-effectiveness of Pembrolizumab Versus Docetaxel As Second-line Treatment of Non-small Cell Lung Cancer In China)
16. Studies from University Hospital Describe New Findings in Non-Small Cell Lung Cancer (Evaluation of Docetaxel Use In Non-small Cell Lung Cancer: Real-world Health Outcomes)
17. Findings from Peking University Broaden Understanding of Monoclonal Antibodies (Evaluation of Efficacy and Toxicity of Nivolumab Combined With or Without Docetaxel In Patients With Advanced Nsclc)
18. Sungkyunkwan University Researchers Report on Findings in Monoclonal Antibodies (Machine Learning for Detection of Safety Signals From Spontaneous Reporting System Data: Example of Nivolumab and Docetaxel)
19. Recent Findings in Prostate Cancer Described by Researchers from Weill Cornell Medicine [Phase I Trial of Docetaxel Plus Lutetium-177-labeled Anti-prostate-specific Membrane Antigen Monoclonal Antibody J591 (Lu-177-j591) for Metastatic ...]
20. Recent Reports from China Pharmaceutical University Highlight Findings in Non-Small Cell Lung Cancer (Cost-effectiveness of Osimertinib vs Docetaxel-Bevacizumab in Third-Line Treatment in EGFR T790M Resistance Mutation Advanced Non-Small Cell ...)
21. Findings in the Area of Non-Small Cell Lung Cancer Reported from Osaka University Graduate School of Pharmaceutical Sciences (Risk Factors for Febrile Neutropenia Induced By Docetaxel Chemotherapy In Patients With Non-small Cell Lung Cancer)
22. Reports Summarize Prostate Cancer Findings from Department of Urology (Docetaxel suppresses immunotherapy efficacy of natural killer cells toward castration-resistant prostate cancer cells via altering androgen receptor-lectin-like transcript 1 ...)
23. Findings on Non-Small Cell Lung Cancer Detailed by Researchers at St. Marianna University School of Medicine (The Impact of EGFR Mutation Status and Brain Metastasis for Non-Small Cell Lung Cancer Treated with Ramucirumab plus Docetaxel)
24. New Data from University of Michigan Illuminate Findings in Colon Cancer (Synthetic HDL Nanoparticles Delivering Docetaxel and CpG for Chemoimmunotherapy of Colon Adenocarcinoma)
25. Study Results from Department of Thoracic Oncology Broaden Understanding of Monoclonal Antibodies (Previous Immune Checkpoint Inhibitor Treatment to Increase the Efficacy of Docetaxel and Ramucirumab Combination Chemotherapy)
26. Data on Monoclonal Antibodies Described by Researchers at National Hospital Organization Shikoku Cancer Center (Previous Immune Checkpoint Inhibitor Treatment to Increase the Efficacy of Docetaxel and Ramucirumab Combination Chemotherapy)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.